Dow ion exchange resin technology is fueling the development of today's most promising pharmaceutical products - making medicines taste better, dissolve faster, last longer and work more effectively. From pills for lowering cholesterol and potassium levels to nicotine lozenges and gums, Dow innovation helps pharmaceutical companies increase the value of their intellectual property with products and technologies that support new formulations, product extensions and generics.

Pharmaceutical Applications

APIs

Dow supplies two Active Pharmaceutical Ingredient (API) intermediates: cholestyramine and polystyrene sulfonate (PSS), used respectively for cholesterol and potassium reduction.

 

BIOPROCESSING

Dow supplies ion exchange resins and reverse osmosis and nanofiltration elements used in drug manufacturing. Dow technologies also allow anti-oxidants, omega-3 and polyphenols to be extracted and purified, so that they may be added to functional foods.

 

FORMULATION

Dow Water & Process Solutions has a long experience within the formulations area and has built a broad portfolio of Advanced Release Technologies based around ion exchange resins to improve the delivery of drugs. In addition to meeting customer requirements for existing products, Dow works with pharmaceutical developers to support new products and meet the ever-increasing demands within the industry.



Learn more about Dow's
Advanced Release Technology
@ www.theartofformulation.com

Learn more about what Dow offers for Biopharmaceutical Processing @ www.advancedbiosciences.com